FindTrial
Sign In

Triphaladi Kwatha will be given to patients of Diabetes mellitus.

Clinical Evaluation of Triphaladi Kwatha in Madhumeha (Type 2 Diabetes Mellitus) - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055416
Enrollment
40
Registered
2023-07-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Arun Verma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing to sign the consent form Patients between the age group of 20-70 years Fasting blood glucose level (FBS)>=126mg/dl Post Prandial blood sugar level (PPBS)>=200mg/dl HbA1c>=6.5%<=13%.

Exclusion criteria

Exclusion criteria: Patients of type 1 Diabetes Mellitus Age below 20years and above 70 years Blood sugar- fasting blood sugar level >350mg/dl Post Prandial blood sugar level >450mg/dl Patients having complications Patients suffering from any serious medical or surgical illness

Design outcomes

Primary

MeasureTime frame
1) PRABHUTA MUTRATA (Excessive Urination) 2) AVILMUTRATA (Turbidity in Urine) 3) KSHUDHA-ADHIKA (Excessive Hunger) 4) PIPSAS ADHIKA (Excessive Thirst) 5) KARA PADA DAHA (Burning Sensation of Hands & Feet) 6) DAURBALYA (Weakness)Timepoint: Assessment will be done every 15th day and the patients will be followed up on 7th day and 14th day after completion of trial—

Secondary

MeasureTime frame
â?¢ BLOOD SUGAR- FASTING â?¢ BLOOD SUGAR-POST PRANDIAL â?¢ HbA1c â?¢ URINE SUGAR â?¢ BODY WEIGHT â?¢ BMITimepoint: At 1st & 90th day.—

Countries

India

Contacts

Public ContactARUN VERMA

UTTARAKHAND AYURVEDA UNIVERSITY GURUKUL CAMPUS HARIDWAR

pandey.punita62@gmail.com9319394485

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026